Evidence map›Paper›PMID 25380620›Full record

ArticleBreast cancer research : BCR2014

Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays.

Karen Jung, Peng Wang, Nidhi Gupta, Keshav Gopal, Fang Wu, Xiaoxia Ye, Abdulraheem Alshareef, Gilbert Bigras, Todd P McMullen, Bassam S Abdulkarim and 1 more

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Karen JungDepartment of Oncology, University of Alberta, Edmonton, Alberta, T6G 2E1, Canada. karenktjung@ualberta.ca.
Peng WangDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, T6G 2E1, Canada. pw2@ualberta.ca.
Nidhi GuptaDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, T6G 2E1, Canada. nidhi2@ualberta.ca.
Keshav GopalDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, T6G 2E1, Canada. gopal@ualberta.ca.
Fang WuDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, T6G 2E1, Canada. fw2@ualberta.ca.
Xiaoxia YeDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, T6G 2E1, Canada. xiaoxia@ualberta.ca.
Abdulraheem AlshareefDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, T6G 2E1, Canada. al15@ualberta.ca.
Gilbert BigrasDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, T6G 2E1, Canada. gilbert.bigras@albertahealthservices.ca.
Todd P McMullenDepartment of Oncology, University of Alberta, Edmonton, Alberta, T6G 2E1, Canada. todd.mcmullen@ualberta.ca.
Bassam S AbdulkarimDepartment of Oncology, McGill University, Montreal, Canada. bassam.abdulkarim@mcgill.ca.
Raymond LaiDepartment of Oncology, University of Alberta, Edmonton, Alberta, T6G 2E1, Canada. rlai@ualberta.ca.
University of Alberta · CAMcGill University · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

introductionAberrant expression of the embryonic stem cell marker Sox2 has been reported in breast cancer (BC). We previously identified two phenotypically distinct BC cell subsets separated based on their differential response to a Sox2 transcription activity reporter, namely the reporter-unresponsive (RU) and the more tumorigenic reporter-responsive (RR) cells. We hypothesized that Sox2, as a transcription factor, contributes to their phenotypic differences by mediating differential gene expression in these two cell subsets.

methodsWe used chromatin immunoprecipitation and a human genome-wide promoter microarray (ChIP-chip) to determine the promoter occupancies of Sox2 in the MCF7 RU and RR breast cancer cell populations. We validated our findings with conventional chromatin immunoprecipitation, quantitative reverse transcription polymerase chain reaction (qPCR), and western blotting using cell lines, and also performed qPCR using patient RU and RR samples.

resultsWe found a largely mutually exclusive profile of gene promoters bound by Sox2 between RU and RR cells derived from MCF7 (1830 and 456 genes, respectively, with only 62 overlapping genes). Sox2 was bound to stem cell- and cancer-associated genes in RR cells. Using quantitative RT-PCR, we confirmed that 15 such genes, including PROM1 (CD133), BMI1, GPR49 (LGR5), and MUC15, were expressed significantly higher in RR cells. Using siRNA knockdown or enforced expression of Sox2, we found that Sox2 directly contributes to the higher expression of these genes in RR cells. Mucin-15, a novel Sox2 downstream target in BC, contributes to the mammosphere formation of BC cells. Parallel findings were observed in the RU and RR cells derived from patient samples.

conclusionsIn conclusion, our data supports the model that the Sox2 induces differential gene expression in the two distinct cell subsets in BC, and contributes to their phenotypic differences.

Indexed as

AC133 AntigenAdenocarcinomaAntigens, CDBreast NeoplasmsChromatin ImmunoprecipitationFemaleGlycoproteinsHumansMCF-7 CellsMucinsPeptidesPhenotypePolycomb Repressive Complex 1Promoter Regions, GeneticReceptors, G-Protein-CoupledReverse Transcriptase Polymerase Chain ReactionAC133 AntigenAntigens, CDBMI1 protein, humanGlycoproteinsLGR5 protein, humanMUC15 protein, humanMucinsPeptidesPolycomb Repressive Complex 1PROM1 protein, humanReceptors, G-Protein-CoupledRNA, Small InterferingSOX2 protein, humanSOXB1 Transcription Factors

Identifiers

PMID25380620
PMCPMC4303205
OpenAlexW2141328595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.